by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Sante Manufacturing Inc. Warning Letter Details

Warning Letter

Sante Manufacturing Inc.

516 John Street N 11A & 11B Aylmer ON N5H 2B8 Canada

Issue DateJune 05, 2026

FEI Number3021535057

Violations4

CountryCanada

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Sante Manufacturing Inc. FDA Warning Letter, June 5, 2026